Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 2.9B
Gross Profit 998.5M 34.51%
Operating Income 590.9M 20.42%
Net Income 492.7M 17.03%
EPS (Diluted) $6.69

Balance Sheet Metrics

Total Assets 3.6B
Total Liabilities 961.1M
Shareholders Equity 2.7B
Debt to Equity 0.36

Cash Flow Metrics

Operating Cash Flow 661.5M
Free Cash Flow 276.4M

Revenue & Profitability Trend

West Pharmaceutical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue2.9B2.9B2.9B2.8B2.1B
Cost of Goods Sold1.9B1.8B1.8B1.7B1.4B
Gross Profit998.5M1.1B1.1B1.2B767.8M
Operating Expenses407.6M421.8M375.4M415.6M348.9M
Operating Income590.9M707.4M760.8M760.2M418.9M
Pre-tax Income585.5M698.0M679.9M748.9M401.3M
Income Tax107.5M122.3M114.7M107.2M72.5M
Net Income492.7M593.4M585.9M661.8M346.2M
EPS (Diluted)$6.69$7.88$7.73$8.67$4.57

Income Statement Trend

West Pharmaceutical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets1.5B1.9B1.9B1.7B1.4B
Non-Current Assets2.1B1.9B1.7B1.6B1.4B
Total Assets3.6B3.8B3.6B3.3B2.8B
Liabilities
Current Liabilities550.4M671.8M519.0M594.1M503.4M
Non-Current Liabilities410.7M276.7M412.9M384.3M435.9M
Total Liabilities961.1M948.5M931.9M978.4M939.3M
Equity
Total Shareholders Equity2.7B2.9B2.7B2.3B1.9B

Balance Sheet Composition

West Pharmaceutical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income492.7M593.4M585.9M661.8M346.2M
Operating Cash Flow661.5M772.1M697.7M579.2M472.3M
Investing Activities
Capital Expenditures-----
Investing Cash Flow-1.7M-6.7M-3.6M300.0K-5.1M
Financing Activities
Dividends Paid-59.1M-57.0M-54.1M-51.1M-48.1M
Financing Cash Flow-655.3M-510.6M-321.8M-205.2M-171.8M
Free Cash Flow276.4M414.5M439.4M330.6M298.1M

Cash Flow Trend

West Pharmaceutical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.96
Forward P/E 29.61
Price to Book 5.96
Price to Sales 5.52
PEG Ratio 29.61

Profitability Ratios

Profit Margin 16.13%
Operating Margin 18.44%
Return on Equity 17.42%
Return on Assets 10.33%

Financial Health

Current Ratio 2.77
Debt to Equity 11.46
Beta 1.09

Per Share Data

EPS (TTM) $6.37
Book Value per Share $37.37
Revenue per Share $39.81

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
wst16.0B34.965.9617.42%16.13%11.46
Intuitive Surgical 184.6B75.4210.7915.96%28.41%0.00
Becton, Dickinson 48.6B32.891.935.89%7.18%76.34
Alcon 42.8B38.451.955.23%11.28%23.63
ResMed 37.3B28.606.7325.81%26.15%15.14
Baxter International 15.4B133.762.17-3.51%-5.20%146.14

Financial data is updated regularly. All figures are in the company's reporting currency.